ReviewCancers2021
PARP Inhibitors and Haematological Malignancies-Friend or Foe?
Kathryn A Skelding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ReviewCancers2021
Kathryn A Skelding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.